How long can a basal‑cell carcinoma on the side of the face remain untreated before it metastasizes or invades surrounding tissue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Delay Treatment—BCC on the Face Should Be Treated Promptly

Basal cell carcinoma on the side of the face should not be left untreated for any predictable timeframe, as local invasion begins immediately and the risk of severe tissue destruction increases substantially with delays of years, though metastasis remains exceedingly rare even after prolonged neglect.

Understanding BCC Growth and Risk

While BCC is characterized by slow growth, the tumor continuously invades surrounding tissue from the moment it develops 1. The critical issue is not metastasis (which is extraordinarily rare) but rather progressive local tissue destruction that becomes increasingly difficult to manage surgically.

What Happens With Delayed Treatment

Local invasion occurs continuously:

  • BCC extends asymmetrically beyond visible borders into surrounding tissue 1
  • Facial location, particularly the "H-zone" (which includes the side of the face), is classified as high-risk regardless of size 1, 2
  • The longer treatment is delayed, the more extensive the tissue destruction and the more complex the required reconstruction

Documented cases of extreme neglect show:

  • A 15-year untreated facial BCC resulted in a 13×15 cm destructive lesion with bone exposure, visual loss, and ultimately pulmonary metastases 3
  • A 10-year untreated facial BCC led to death from sepsis and hypothermia due to extensive ulceration 4
  • A 6-year delay resulted in lymph node metastasis 5
  • A 14-year untreated BCC caused death from sepsis and complications 4

Why Facial Location Demands Urgent Treatment

Facial BCCs are high-risk because:

  • They can invade critical structures (eyes, nose, ears, bone)
  • Recurrence rates are higher even after treatment 2
  • Reconstruction becomes exponentially more complex with larger defects
  • Mohs micrographic surgery is the recommended treatment for facial BCC, offering the lowest recurrence rate (1.0% for primary tumors) 2

The Metastasis Question

Metastasis is exceptionally rare but does occur:

  • Typically only happens after years to decades of complete neglect 3, 4, 5
  • Most commonly spreads to lymph nodes first, then lungs 3, 5, 6
  • Requires massive local tumor burden before distant spread occurs
  • The real danger is local destruction, not metastasis

Clinical Recommendation

There is no "safe" waiting period for facial BCC. The tumor should be evaluated and treated as soon as diagnosed because:

  1. Immediate treatment preserves function and cosmesis with minimal tissue loss
  2. Delays of even months to years increase the surgical defect size and complexity
  3. Recurrence rates increase when margins are compromised by larger tumors 1
  4. 56% of recurrences occur beyond 5 years after treatment, emphasizing the importance of early definitive therapy 2

Common Pitfall to Avoid

Do not reassure patients that BCC "never metastasizes" or that delays are harmless. While metastasis is rare, local tissue destruction is guaranteed with time and creates devastating functional and cosmetic consequences that could have been easily prevented with prompt treatment 3, 4, 7.

The answer to "how long can I wait" is: you shouldn't wait at all. Schedule definitive treatment (preferably Mohs surgery for facial location) as soon as feasible 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.